Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepaticVX2 tumor in rabbits by intravenous injection

被引:30
作者
Hu, Jun [1 ]
Liu, Zhi-Su [1 ]
Tang, Sheng-Li [1 ]
He, Yue-Ming [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan 430071, Hubei Province, Peoples R China
关键词
hydroxyapatite nanoparticles; rabbit VX2; liver carcinoma; p53; c-myc;
D O I
10.3748/wjg.v13.i20.2798
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the effect of hydroxyapatite nanoparticles (Nano HAP) by intravenous injection on the inhibition of implanted hepatic VX2 tumor growth in rabbits and cell p53/c-Myc protein expression. METHODS: 60 hepatic VX2 tumor-bearing rabbits was randomly divided into five groups. Nano HAP collosol 20 mg/kg, 40 mg/kg, 5-FU solutions 20 mg/mL, mixed liquor of 5-FU solution 20 mg/mL and Nano HAP collosol 20 mg/kg were infused by vein, normal saline conducted as the control. The general state, weight, liver function and gross tumor volume were detected dynamically. The expression of p53 and c-Myc gene protein in tumor tissue was detected by immunohistochemistry methods. RESULTS: The growth of implanted hepatic VX2 tumors was significantly inhibited in all therapy groups, 3 wk after the injection, the tumor control rates in Nano HAP collosol groups were 25.5% and 32.5% respectively, and the gross tumor volumes were obviously less than that of control group. (24.81 +/- 5.17 and 22.73 +/- 4.23 vs 33.32 +/- 5.26, P < 0.05). The tumor control rate of 5-FU group was 43.7% (18.74 +/- 4.40 vs 33.32 +/- 5.26, P < 0.05), but the general state of the animals after injection aggravated; and the adverse reaction in the drug combination group obviously decreased. Due to the effect of Nano HAP, the positive expression of tumor associated the mutated p53 and c-Myc in tumor tissue was decreased obviously compared with the control group. CONCLUSION: Nano HAP has evident inhibitory action on rabbit implanted hepatic VX2 tumor in vivo, which may be the result of decreasing the expression of the mutated p53 and c-myc, and drug combination can obviously decrease the adverse reaction of 5-FU. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2798 / 2802
页数:5
相关论文
共 13 条
[1]  
Aoki H, 1999, J MATER SCI-MATER M, V11, P67
[2]   Effects of nano HAP on biological and structural properties of glass bone cement [J].
Fu, Q ;
Zhou, N ;
Huang, WH ;
Wang, DP ;
Zhang, LY ;
Li, HF .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 74A (02) :156-163
[3]   In vitro assessment of the biological response to nano-sized hydroxyapatite [J].
Huang, J ;
Best, SM ;
Bonfield, W ;
Brooks, RA ;
Rushton, N ;
Jayasinghe, SN ;
Edirisinghe, MJ .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2004, 15 (04) :441-445
[4]   Study on adsorption mechanism of proteins onto synthetic calcium hydroxyapatites through ionic concentration measurements [J].
Kandori, K ;
Masunari, A ;
Ishikawa, T .
CALCIFIED TISSUE INTERNATIONAL, 2005, 76 (03) :194-206
[5]   IMPLANTATION TREATMENT METHOD OF SLOW RELEASE ANTICANCER DOXORUBICIN CONTAINING HYDROXYAPATITE (DOX-HAP) COMPLEX - A BASIC STUDY OF A NEW TREATMENT FOR HEPATIC CANCER [J].
KUNIEDA, K ;
SEKI, T ;
NAKATANI, S ;
WAKABAYASHI, M ;
SHIRO, T ;
INOUE, K ;
SOUGAWA, M ;
KIMURA, R ;
HARADA, K .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :668-673
[6]   Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells [J].
Liu, ZS ;
Tang, SL ;
Ai, ZL .
WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) :1968-1971
[7]   Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs [J].
Mizushima, Y ;
Ikoma, T ;
Tanaka, J ;
Hoshi, K ;
Ishihara, T ;
Ogawa, Y ;
Ueno, A .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :260-265
[8]  
Niwa M, 1999, BIO-MED MATER ENG, V9, P163
[9]   The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions [J].
Pezzatini, S ;
Solito, R ;
Morbidelli, L ;
Lamponi, S ;
Boanini, E ;
Bigi, A ;
Ziche, M .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (03) :656-663
[10]   Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections [J].
Rauschmann, MA ;
Wichelhaus, TA ;
Stirnal, V ;
Dingeldein, E ;
Zichner, L ;
Schnettler, R ;
Alt, V .
BIOMATERIALS, 2005, 26 (15) :2677-2684